How Does This Healthcare Supplier Operate?
Medline Inc operates in health care, supplying products and services used across clinical settings. The business is built around moving high volumes reliably, with day-to-day performance shaped by purchasing, distribution, and fulfillment. Its footprint is large enough to matter to enterprise buyers that care about consistency and availability. With a USD 45.3 billion market cap, it sits at a scale where operational discipline tends to show up quickly in the numbers.
Are Margins Holding as Revenue Expands?
FundamentalsFor 2025, reported in USD, Medline generated about USD 28.4 billion of revenue, with EBIT of roughly USD 2.2 billion and net income of about USD 1.16 billion. The margin stack shows how the model converts volume into earnings: a 25.86% gross margin steps down to a 7.08% operating margin and a 3.32% net margin.
Cash conversion was supported by a large non-cash depreciation base relative to spending needs. Depreciation and amortization totaled about USD 1.0 billion against capital expenditure of roughly USD 58 million, producing a cash flow proxy of about USD 3.1 billion. The balance sheet showed around USD 1.9 billion of cash alongside USD 77 million of total debt.
Is the Stock Fairly Priced Now?
DCF / MultiplesAt USD 34.45, the stock is priced close to the DCF’s central estimate of USD 36.20, between a weaker outcome around USD 21.85 and a stronger outcome around USD 52.53. The headline multiples alongside that setup include a 46.88x trailing P/E and a 1.55x price-to-sales ratio.
Execution Must Stay Steady
TakeawayThe business is running on scale, but profits are thin at the bottom line. Durability here depends on holding margins while keeping costs controlled. Cash generation looks supported by low capex needs. If margins compress, earnings can fall quickly. At today’s price, execution has to stay steady.